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Aims

Psychological distress and changes in health-related quality of life (HRQoL) may occur after screening for disease. Reporting outcomes related to potential beneﬁts and harms of screening is a key recommendation in the guidelines for reporting high-quality
trials or interventions. However, no reviews have directly investigated outcomes related to psychological distress and/or changes
in HRQoL following imaging assessment of cardiovascular risk and communication of cardiovascular ﬁndings to asymptomatic
adults. A scoping review was conducted to map research on psychological distress and/or HRQoL following screening.
.........................................................................................................................................................................................
Methods
Six electronic databases (MEDLINE, PsychINFO, Social Work Abstracts, Psychology and Behavioural Sciences Collection,
CINAHL, and EMBASE) were searched for articles that assessed psychological distress and/or HRQoL following screening.
and results
Two investigators independently screened titles and abstracts for all records retrieved using predeﬁned criteria. Studies
were conducted among active smokers, military personnel, athletes, post-menopausal women, and high-risk individuals.
Seven constructs related to psychological distress and HRQoL appeared across 11 articles (randomized controlled trials,
n = 4 and non-randomized studies, n = 7). Worry, depression, perceived stress, anxiety, and quality of life were most prominent. Multiple-item measures of psychological distress (e.g. Taylor Anxiety Score and Beck Depression Inventory) were
used in 5/9 (56%) studies. Key ﬁndings on psychological distress and/or changes in HRQoL following screening were mixed.
.........................................................................................................................................................................................
Conclusions
Findings support the need for multiple-item measures with better psychometric properties to examine the psychological
responses to screening results in future studies. Strategies to support individuals during and following vascular screening to
maximise potential beneﬁts of screening and minimize harms are discussed.
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Seven constructs related to psychological distress and health-related quality of life were identiﬁed.
Effects of imaging results on psychological distress varied and were most often associated with the communication of cardiovascular ﬁndings
to participants.
Multiple-item measures of psychological distress were used in most of the studies that assessed psychological responses to vascular screening results.
Strategies to support individuals during and following vascular screening to maximise potential beneﬁts of screening and minimize harms are
reported.

Introduction
Cardiovascular disease (CVD) refers to a class of diseases involving
the blood vessels or heart.1 The World Health Organization estimated that 17.9 million people died from CVD in 2019, representing
almost one-third of all global deaths.2 Coronary and cerebrovascular
events, such as a heart attack or stroke, constitute 85% of all
CVD-related deaths.2 Atherosclerosis is the main pathological process responsible for most acute coronary and cerebrovascular
events.3 Non-invasive vascular imaging of the carotid and coronary

arteries are commonly used to screen for the presence of
atherosclerotic plaques or asymptomatic CVD.4–8 Screening for
asymptomatic CVD provides an opportunity to initiate risk factor
management to prevent the progression of disease before the occurrence of adverse cardiac or cerebrovascular events.9,10 Screening for
asymptomatic CVD can also inform risk classiﬁcation and the design
and implementation of tailored prevention strategies.11 Carotid and
coronary atherosclerosis screening by non-invasive imaging are important for (i) increasing awareness and understanding of the personal risk of cardiac events, (ii) gaining greater control over
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Methods
This scoping review is reported according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analysis Extension for Scoping
Reviews (PRISMA-ScR) reporting criteria.44 We used the framework initially designed by Arksey and O’Malley45 and updated by Levac et al.46
and Peters et al.47–49 to identify, select, collate, summarise, and report
the evidence. A scoping review was the most appropriate due to
the nature of the evidence and the lack of comprehensive reviews on
this topic.50 A protocol was published to describe the methods and conduct of this review.51

Information sources and search strategy
Articles were identiﬁed via EBSCOhost [MEDLINE, PsychINFO, Social
Work Abstracts, Psychology and Behavioural Sciences Collection, and
Cumulative Index to Nursing and Allied Health Literature (CINAHL)]
and EMBASE databases without the year of publication or language restrictions. The complete electronic search strategy for EBSCO and
EMBASE databases is included in Supplementary material online,

File S1. Additional records were identiﬁed through reference lists
searches (e.g. manual screening of individual studies retrieved) and grey
sources (e.g. Open Grey and Open Access Theses and Dissertations).
We used this diverse array of sources to capture a complete picture
of the state of the literature on the topic.

Eligibility criteria
Studies that were conducted among adults (≥18 years) who were
asymptomatic or had no symptoms of atherosclerosis (not diagnosed
with angina or screened due to clinical symptoms of angina or chest
pain, or intermittent claudication), and without a known history of
CVD (e.g. myocardial infarction or heart attack, transient ischaemic attack, stroke, and/or peripheral arterial disease) were included in this review (see Supplementary material online, File S2). Participants were
screened using non-invasive vascular imaging modalities [e.g. Electron
Beam Computed Tomography (EBCT), Double-Helical Computed
Tomography, and B-mode ultrasound] to detect atherosclerotic
plaques in the coronary and carotid arteries. Participants were also examined for outcomes related to psychological distress (e.g. anxiety, depression, worry, and perceived stress) and/or HRQoL (e.g. appraisals of
wellness, physical and mental health functional status) following
screening.

Selection of evidence
Two investigators (R.A. and J.R.L.) independently screened titles and abstracts for all records retrieved from the selected databases and manual
search of reference lists to agree on inclusion and exclusions. Articles
that met inclusion criteria were retained for full-text review (Figure 1).
Two investigators (R.A. and J.R.L.) independently screened full-text articles to determine the eligibility of articles for inclusion and agreed on the
exclusions. Data from included studies were extracted. No risk of bias
assessment was included as it is not relevant to the objectives of this
scoping review.

Data charting
A tabular form of charting was used to chart information including the
name of the ﬁrst author, year of publication, study purpose, design
and setting, study population, intervention, data collection instruments and outcomes. Data on how results were provided, details
of results, follow-up period after baseline screening and any additional support (e.g. counselling/lifestyle recommendations) were also
extracted.

Synthesis and reporting of the results
We grouped and synthesized results based on outcomes. Outcomes
fell into two broad categories related to HRQoL and psychological distress. We also described study characteristics including study type/purpose, sample characteristics, imaging techniques, outcome assessment
instruments, follow-up period after screening, and gaps in existing
knowledge.
We compared and reported outcomes differently based on the
type of study designs employed by the included studies. For the prospective non-randomized studies, we compared outcomes between
groups [e.g. coronary artery calcium (CAC) present group vs. CAC
absent group or low-risk group vs. moderate-risk group vs. high-risk
group]. We reported outcomes on psychological distress and
HRQoL before and after the interventions (provision of imaging results) in studies that used pre–post study designs. Outcomes reported
for the randomized controlled trials (RCTs) are based on groups that
were screened and received imaging results compared to groups that
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decisions and actions affecting one’s health, and (iii) the prevention of
clinical disease.12
Screening ﬁndings suggesting abnormalities in the coronary or carotid arteries and standard information about risk (i.e. abnormalities
or plaques in the coronary and carotid arteries increase one’s risk of
stroke, heart attack, and death) are communicated to individuals in
different forms (e.g. verbal, written, detailed discussions or conversations).13–16 Information suggesting susceptibility to a condition, particularly if the condition is perceived as potentially having serious
consequences, can be considered a severe life stressor or
threat.17–20 Several factors such as self-efﬁcacy, coping resources,
cognitive regulation and individual traits may modulate the type of
response to a perceived threat.17,18,21,22 Defensive or adaptive
behaviours (e.g. higher smoking cessation rates and dietary changes)
can be evoked by threatening stimuli and may improve health outcomes.5–7,17,18,21,23–25 However, not all individuals will engage in
adaptive behaviours or experience positive health outcomes when
exposed to a perceived threat.18–20,26–37 Individuals who do not
have the emotional and/or mental capacity to process a stressful situation may be susceptible to psychological harm when exposed to a
perceived threat.18–20,28–38 Receiving positive screening test results
related to a major medical condition can lead to elevated fear, concerns related to personal health, psychological distress (e.g. high rates
of anxiety and depression), and changes in health-related quality of
life (HRQoL).28,38–41 It is therefore important to examine both the
potential beneﬁts and harms of screening.42
Examining psychological distress and changes in HRQoL following screening to detect disease is necessary and important for identifying individuals who are at an increased risk of experiencing
psychological distress and/or impaired HRQoL immediately or
over time.43 Information from this scoping review will guide researchers and clinicians to design interventions that best support
asymptomatic adults who may undergo vascular screening to prevent any negative psychosocial outcomes. This paper reports a
scoping review with the key aim to (i) identify, map, and organise
the evidence on psychological distress and HRQoL following the
provision of vascular imaging results and (ii) identify knowledge
gaps in the existing studies.
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were not screened using imaging or did not receive any vascular imaging results.

All the articles that met the inclusion criteria were peer-reviewed
(Table 1).

Characteristics of studies

Results
Selection and sources of evidence
The purpose of this scoping review was to report the scope and nature of evidence on psychological distress and HRQoL following the
provision of vascular imaging results. We retrieved a total of 1284
articles using the search strategies (see Supplementary material online, Supplementary File S1) and 26 articles using grey literature
sources and reference list searches. Of these, 37 were accessed in
full text, and 11 met the inclusion criteria as depicted in Figure 1.

Study setting and population
Studies were conducted in different settings (i.e. hospital, medical
centre, and radiology centre) and included both male and female participants aged ≥28 years. The number of participants included in the
studies ranged from 30 to 1169. Caucasians were included in some
studies (n = 3)52–54, whereas ethnicities were mixed (n = 3)13,14,55 or
not speciﬁed (n = 5)56–60 in other studies. Most studies were conducted in the USA (n = 7), followed by Switzerland (n = 2),
Denmark (n = 1), and the Netherlands (n = 1) (Table 1).
Participants with personal/known history or symptoms of CVD
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Figure 1 Summary of the search, selection, and inclusion process.
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Summary of literature

Study details
n
%
.......................................................................................
Year of publication
1996–2005

3

27

2006–2015

7

64

2016 to current

1

9

Pre–post design studies (peer-reviewed articles)

3

27

Prospective studies (peer-reviewed articles)

4

36.5

Randomized controlled trial (RCT) (peer-reviewed

4

36.5

Secondary research (e.g. reviews)

0

0

Grey literature (non-peer-reviewed articles)

0

0

Smokers

3

27

Athletes

1

9

Active-duty army personnel

1

9

Post-menopausal women

1

9

Adults at risk of CVD due to one or more risk factors

5

46

USA

7

64

Switzerland

2

18

Denmark

1

9

Netherlands

1

9

Record type/source

articles)

Population

Location

were excluded from all studies. Only two studies reported excluding
participants with psychiatric disease.58,59 Of these, a study also reported excluding participants who were identiﬁed as consuming a
high level of alcohol, used cannabis in the past 3 months or related
drugs.59 Full list of studies included and details of participant inclusion/exclusion in individual studies have been provided in
Supplementary material online, Supplementary Files S2 and S3.

Study designs, screening, and behavioural strategies
Study designs/types included RCTs (n = 4), pre–post (n = 3), and
prospective non-randomized studies (n = 4) (Table 1). Imaging methods included computed tomography (e.g. Cardiac Computed
Tomography,
Double-Helical
Computed
Tomography,
non-contrast-enhanced Cardiac CT, Multidetector Computed
Tomography, EBCT, and Low-dose Coronary Computed
Tomography) and carotid ultrasound (e.g. B-mode ultrasound).
Screening results and their interpretation were provided by healthcare professionals (n = 3), study investigators (n = 2) or unspeciﬁed
(n = 6). Common behavioural support to facilitate adherence to lifestyle recommendations following screening included advice for lifestyle modiﬁcation, smoking cessation counselling, intensive case
management (ICM), and the nicotine replacement therapy (NRT).
Further details of these aspects and information from included studies are provided in Supplementary material online, Supplementary
Files S3 and S4.

Measures of psychological distress and health-related
quality of life following screening
Measures of psychological distress following screening included
multiple-item scales (56%, n = 5) and single-item measures (44%,
n = 4). The use of single-item measures (e.g. a single question to assess
worry following screening) was reported in some studies
(n = 4).13,14,53,60 In other studies, multiple-item scales such as Taylor
Anxiety Score (n = 1), Major Depression Inventory questionnaire
(n = 1), Beck Depression Inventory (n = 1), PRIME-MD self-reported
Patient Health Questionnaire (n = 1), Perceived Stress Scale (n = 1),
and Impact of Event Scale (IES) (n = 1) were used. HRQoL was
examined using the Short-Form Health Survey questionnaire (SF-36)
(n = 4),52,55,58,59 Ferrans and Powers Quality of Life Index Cardiac IV
(QoL Index) (n = 1),14 and Perceived Wellness Score (n = 1).56

Outcomes related to psychological
distress and health-related quality of life
Psychological distress
A total of nine studies reporting outcomes on psychological
distress following the provision of vascular imaging results were
included in this review (Table 2).13,14,53–55,57–60 These included
RCTs (n = 2),55,59 pre–post studies measuring outcomes
before-and-after screening results were provided (n = 3),14,57,58
and prospective studies (n = 4).13,53,54,60 Outcomes related to psychological distress included anxiety (n = 3), depression (n = 4), worry (n = 4), and perceived stress (n = 3). Outcomes were measured at
baseline and between 2 and 30 months after vascular screening. The
type of results provided/medium, outcome assessment instruments,
participant details, individuals who provided support, and the type of
support provided following screening for each of the studies included
in this review can be found in Supplementary material online,
Supplementary File S3. All key ﬁndings related to psychological
distress and outcome measures are presented in Supplementary material online, Supplementary File S4.
Randomized controlled trials
Overall, two RCTs reporting outcomes related to psychological distress following the provision of vascular imaging results were identiﬁed in the literature.55,59 One RCT showed no signiﬁcant effect of
imaging, with or without intensive case management, on symptoms
of anxiety, depression, and stress scores measured at 12 months
of post-screening.55 Another RCT showed no signiﬁcant difference
in perceived stress, anxiety, and depression scores in the intervention (imaging and smoking cessation program) and control (smoking
cessation program) groups, and between those who had plaques or
disease and those without plaques at 12-month follow-up.59
Pre–post non-randomized studies
We found three pre–post or before-and-after studies that reported
outcomes on psychological distress (e.g. depression, anxiety, perceived stress, and worry) following screening.14,57,58 Findings on psychological distress following the provision of vascular imaging results
were mixed. A signiﬁcant decrease in worry levels was found in participants in the lower CAC scores group at 3-month follow-up in one
study.14 However, three studies reported no signiﬁcant increases in
depression scores, perceived stress, anxiety, and worry levels in
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Outcomes examined in included studies

Authors/Year

Anxiety

Depression

Worry

Perceived stress

Impact of event/
Perceived
QoL
post-traumatic stress
wellness
...............................................................................................................................................................................................
✓

Johnson et al. (2015)14

✓
✓

Lederman et al. (2007)56
✓

Nielsen et al. (2012)57

✓

52

Obuchowski et al. (2007)
O’Malley et al. (2003)55

✓

✓

✓

✓

Rodondi et al. (2008)58

✓

✓

✓

✓

✓

✓

✓

Rodondi et al. (2012)59
Rupard et al. (2002)

✓

13

✓

Sandwell et al. (2006)53
Schurink et al. (2017)54
Wong et al. (1996)60

✓

✓
✓

participants with higher CAC scores at 2, 3 and 6 months postscreening.14,57,58 Also two studies found lower scores for anxiety,
depression, and perceived stress in participants with abnormal results following screening.57,58

Prospective non-randomized studies
Outcomes on psychological distress were reported in four prospective studies.13,53,54,60 Outcomes reported included worry (n = 3),
anxiety (n = 1) and post-traumatic stress (clinically relevant and
less severe psychological distress examined using IES) (n = 1) following the provision of vascular imaging results.53,54,60 Three out of four
studies found that worry of developing coronary artery disease, anxiety or psychological distress signiﬁcantly increased with higher CAC
scores/presence of CAC at 6 months, mean 16 months, and 12–24
months post-screening.53,54,60 The other study showed no signiﬁcant
difference in worry levels between coronary artery calciﬁcation present and absent groups. Worry was assessed at an average of 8
months after screening.13

Health-related quality of life
HRQoL was examined in six studies—four RCTs52,55,56,59 and two
pre–post studies.14,58 Outcomes were assessed at baseline, and
within 2–24 months after vascular screening.

Randomized controlled trials
HRQoL was reported in four RCTs following screening.52,55,56,59
One RCT showed a signiﬁcant difference in ‘role physical’ (fewer
physical health problems for screened participants) between CT
screened participants and participants in the control group at 24
months.52 The scores were similar for screened and control participants for the other seven subscales of the SF-36 survey questionnaire.52 Three RCTs showed no evidence of any effect of imaging
results or vascular screening on HRQoL.55,56,59 Outcomes were assessed at baseline and 12-month follow-up.55,56,59

Pre–post non-randomized studies
Findings regarding HRQoL post-screening were mixed.14,58 One
study14 found no signiﬁcant differences at 3-month follow-up in
HRQoL in the ﬁve CAC score risk groups (i.e. no risk/normal, very
low risk, mild risk, moderate risk, and high risk).14 Another study58
showed a signiﬁcant change in HRQoL in the group with plaques
or those who received abnormal results (i.e. signiﬁcant increases in
both mental and physical health scores) at 2-month follow-up.

Discussion
Overall, 11 articles reporting outcomes on psychological distress and
HRQoL following the provision of vascular imaging results were
identiﬁed in this scoping review. Outcomes related to psychological
distress and HRQoL following the provision of vascular imaging results were reported in RCTs, pre–post, and prospective studies.
This is, to our knowledge, the ﬁrst review to report the scope and
nature of evidence in this area.
Key ﬁndings on psychological distress following screening were
generally mixed. When analysing individual studies, we found three
prospective studies that reported signiﬁcant increases in worry, anxiety, and psychological distress among some individuals who were informed about abnormalities in their coronary arteries.53,54,60
Previous research has also demonstrated that information about increased risks of illness can induce psychological distress.40,61,62
However, some pre–post studies included in this review found lower
scores for anxiety, depression, and perceived stress at follow-up in
participants who were informed about abnormalities in their coronary or carotid arteries.57,58 Higher levels of anxiety, depression, and
stress before the provision of screening results can be attributed to
the processes involved with the screening or uncertainty associated
with screening and results. Others have reported that other components of screening such as invitation for screening, attending the routine screening or waiting at a screening clinic can precipitate
psychological distress.63,64 Uncertainty about outcomes of screening
may have also resulted in higher levels of anxiety before screening
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Table 2
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or threat and therefore lead to different responses, it is important
that individuals who undergo screening are provided with psychosocial support. There are, however, different guidelines concerning
what should follow the provision of positive screening results. For
example, the United Kingdom guidance for cancer screening suggests
that the provision of positive screening results should be followed by
psychological support.71 Further, the Canadian and USA guidance
advocate clinical assessment before any consideration to referring individuals for psychological intervention.72,73 To our knowledge,
there is no speciﬁc guidance as to what criteria or assessment should
be undertaken before the offer of psychological support (e.g. support groups) or referral for therapeutic support.
Common behavioural support to facilitate adherence to lifestyle
recommendations reported in the studies included in this review
were advice/counselling for lifestyle modiﬁcation, smoking cessation
counselling, ICM, and the NRT. Other behavioural lifestyle interventions aimed at improving the management of other conditions (e.g.
obesity) have utilized varying levels of behavioural and psychological
support to improve adherence to lifestyle recommendations.74–77
These included individual psychotherapy, group psychodynamic
therapy (for developing problem-solving strategies, emotional expression, and improving body perception), cognitive-behavioural
programme, and individual and group counselling.74–77 Future studies
could maximise the potential beneﬁts of providing vascular imaging
results to participants by incorporating other stress management
techniques
and
psychosocial
interventions,
such
as
Cognitive-Behavioural Stress Management (CBSM), which has been
demonstrated to decrease negative mood and perceived stress.78
CBSM is also useful for changing cognitive appraisals, improving perceived social support, facilitating problem-focused coping, and decreasing sympathetic nervous system arousal and release of stress
hormones such as cortisol.78,79 Stress management strategies can
support participants to be less reactive to screening results while empowering them to modify their lifestyle to prevent any clinical disease. For example, the Cognitive Emotional Behavioural Therapy
may help improve self-esteem and reduce emotional eating, anxiety
and depression.80
Other moderators of behaviour such as self-efﬁcacy and perceived
control were not accounted for or adjusted when reporting outcomes on psychological distress and/or HRQoL in the studies.
Also, some RCTs did not report the effects of severity of disease
(i.e. CAC scores and carotid plaque presence) on psychological distress and/or HRQoL.52,55 Though positive self-efﬁcacy beliefs are not
the only cause of important outcomes, they may play a crucial role in
how individuals react to screening results. For example, individuals
with a strong sense of self-efﬁcacy approach threatening situations
with the belief that they can manage or control them.37 This has
been linked to lower vulnerability to depression and lower levels
of stress.37 Also, individual response to threat may be dependent
on the severity of the perceived threat;17,18,21,25 therefore, it’s unclear why the severity of asymptomatic disease shown in the results
was not considered in the analysis of outcomes in some studies.

Implications for practice
This review provides implications for practice and future research on
cardiovascular screening. Clinical assessment for psychological distress and the use of more reliable and/or comprehensive instruments
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results were provided.65 The ﬁndings can also be partly attributed to
the timeframe of follow-up assessments.
Findings related to HRQoL following the provision of screening
results were also mixed. However, we did ﬁnd one pre–post study
that showed signiﬁcant changes in HRQoL (in the form of increases
in mental and physical health scores) 2 months of post-screening.
Findings related to HRQoL in this pre–post study were reported
based on information from the International Quality of Life
Assessment (IQOLA) Project.66 Findings of the IQOLA Project
SF-36 survey suggest that higher scores indicate less disability, improvement in quality of life or a more favourable health state.66
Highest possible score for physical component summary (PCS)
may indicate no disabilities, less physical limitations, or high energy
level.66 Highest possible score for mental component summary
(MCS) may indicate no symptoms of psychological distress, frequent
positive affect, or absence of limitations in performing daily duties
due to emotional problems.66 Therefore, ﬁndings suggesting signiﬁcant increases in mental and physical health scores following carotid
plaque screening are encouraging. Changes in HRQoL following
screening may be attributed to stress responses (i.e. positive/negative
appraisals of stress), coping options, and participants’ abilities to
engage in behaviours that can impact their overall HRQoL.17,18 It is
possible that some participants also felt powerless in relation to their
future outcomes, and would not engage in any recommended
preventive behaviours that can improve HRQoL.
Our review shows that outcomes on psychological distress were
assessed using only self-reported measures. We suggest that the
inclusion of clinical assessments and/or well-validated measures of
self-reported symptom severity are considered when designing
such interventions. This may be useful to identify potential psychological impacts of imaging that may be difﬁcult to detect via selfreport assessments. In many instances, we also found that studies
measured only one psychological variable (e.g. worry) following the
provision of imaging results.13,14,53,60 Adding more components of
psychological assessment such as anxiety and depression following
screening may have important implications for the overall evaluation
of psychological distress following screening. Also, psychological distress was assessed in some studies using single-item measures.13,14,53,60 Multiple-item measures are often viewed as having
better psychometric properties.67
The SF-36 questionnaire was mostly used for evaluating HRQoL in
the studies included in this review. The SF-36 is a very popular instrument for evaluating HRQoL and measures two distinct concepts—a
physical dimension using physical component summary scores, and a
mental dimension using mental component summary scores.68 PCS
and MCS are evaluated by the scoring of eight scales including role
physical, physical functioning, vitality, general health, social functioning, bodily pain, role emotional, and mental health. Though SF-36 is
widely used to evaluate HRQoL, the validity of this instrument as a
total measure of HRQoL is often questioned in cases when the special algorithms for calculating summary measures are not used68–70
and it is unclear whether special algorithms were used in the studies
we included in this review. Future studies can improve the measure
of HRQoL by using the special algorithms for calculating summary
measures of PCS and MCS.70
Given that the provision of information suggesting the existence of
disease or poor health status can be considered a severe life stressor
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Limitations
Only studies reporting carotid or coronary artery plaque screening were included in this review. There is also a possibility that
this review may have missed some studies due to database selection or where studies were published. Moreover, the instruments that were used to assess psychological distress and
HRQoL (e.g. SF-36) following screening have several weaknesses.
However, this review provides important information that will
be useful for researchers and clinicians to design interventions
that best support individuals who may undergo vascular
screening.

Conclusions
Screening for asymptomatic CVD with non-invasive imaging can
help identify vascular disease in its subclinical phase; therefore,
providing an opportunity to initiate risk factor management before the occurrence of any advanced disease or adverse cardiac
events. However, screening ﬁndings suggesting the existence of
disease may lead to different emotional responses impacting
HRQoL. Our review has covered the breadth of evidence on
psychological distress and HRQoL following the provision of
non-invasive vascular imaging results. We have identiﬁed key
gaps and described key interventions and strategies that could
maximise positive outcomes in future interventions and reduce
the potential harms of screening. Moreover, our review shows
that measures of psychological responses to vascular screening
can be improved.

Supplementary material
Supplementary material is available at European Journal of
Cardiovascular Nursing.

Funding
R.A. is supported by an Australian Government Research Training
Programme Scholarship (International). The salary of L.C.B. is supported
by an NHMRC of Australia Emerging Leadership Investigator Grant (ID:
1172987) and a National Heart Foundation of Australia Post-Doctoral
Research Fellowship (ID: 102498). The salary of J.R.L. is supported by
a National Heart Foundation Future Leader Fellowship (ID: 102817).
The salary of J.M.H. is supported by a National Health and Medical
Research Council of Australia Senior Research Fellowship (ID: 1116973).
Conﬂict of interest: There are no conﬂicts of interest.

Data availability
The authors conﬁrm that the data supporting the ﬁndings of this
study are available within the article and its online supplementary
materials.

References
1. Mendis S, Puska P, Norrving B. World Health Organization. Global Atlas on
Cardiovascular Disease Prevention and Control: World Health Organization; 2011.
2. World Health Organization. Cardiovascular diseases (CVD) fact sheet. 2021.
3. World Health Organization. Prevention of Cardiovascular Disease: Guidelines for
Assessment and Management of Total Cardiovascular Risk: World Health
Organization; 2007.
4. Mamudu HM, Paul TK, Veeranki SP, Budoff M. The effects of coronary artery calcium
screening on behavioral modiﬁcation, risk perception, and medication adherence
among asymptomatic adults: a systematic review. Atherosclerosis 2014;236:338–350.
5. Rodondi N, Auer R, de Bosset Sulzer V, Ghali WA, Cornuz J. Atherosclerosis screening by noninvasive imaging for cardiovascular prevention: a systematic review. J Gen
Intern Med 2012;27:220–231.
6. Hackam DG, Shojania KG, Spence JD, Alter DA, Beanlands RS, Dresser GK, Goela A,
Davies AH, Badano LP, Poldermans D, Boersma E, Njike VY. Inﬂuence of noninvasive
cardiovascular imaging in primary prevention: systematic review and meta-analysis of
randomized trials. Arch Intern Med 2011;171:977–982.
7. Gupta A, Lau E, Varshney R, Hulten EA, Cheezum M, Bittencourt MS, Blaha MJ,
Wong ND, Blumenthal RS, Budoff MJ, Umscheid CA, Nasir K, Blankstein R. The
identiﬁcation of calciﬁed coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review
and meta-analysis. JACC: Cardiovasc Imaging 2017;10:833–842.
8. Tarkin JM, Dweck MR, Evans NR, Takx RA, Brown AJ, Tawakol A, Fayad ZA, Rudd
JHF. Imaging atherosclerosis. Circ Res 2016;118:750–769.
9. Rozanski A, Muhlestein JB, Berman DS. Primary prevention of CVD: the role of imaging trials. JACC: Cardiovasc Imaging 2017;10:304–317.
10. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ,
Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD,
Muñoz D, Smith SC, Virani SS, Williams KA, Yeboah J, Ziaeian B. ACC/AHA guideline
on the primary prevention of cardiovascular disease: executive summary: a report of
the American College of Cardiology/American Heart Association Task Force on
Clinical Practice Guidelines. J Am Coll Radioly 2019;74:1376–1414.
11. Faggiano P, Dasseni N, Henein M. Imaging Subclinical Atherosclerosis Promises Better
Cardiovascular Primary Prevention. London, UK: Sage Publications Sage; 2019.
12. Task Force Members, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, et al.
European Guidelines on cardiovascular disease prevention in clinical practice: the
sixth joint task force of the european society of cardiology and other societies on
cardiovascular disease prevention in Clinical Practice (constituted by representatives
of 10 societies and by invited experts): developed with the special contribution of
the European Association for Cardiovascular Prevention & Rehabilitation
(EACPR). Eur J Prev Cardiol 2016;23:NP1–NP96.
13. Rupard EJ, O’Malley PG, Jones DL, Feuerstein I, Brazaitis M, Taylor AJ. Does the diagnosis of coronary calciﬁcation with electron beam computed tomography motivate
behavioral change in smokers? Mil Med 2002;167:211–214.
14. Johnson JE, Gulanick M, Penckofer S, Kouba J. Does knowledge of coronary artery
calcium affect cardiovascular risk perception, likelihood of taking action, and healthpromoting behavior change? J Cardiovasc Nurs 2015;30:15–25.
15. Korcarz CE, DeCara JM, Hirsch AT, Mohler ER, Pogue B, Postley J, Tzou WS, Stein
JH. Ultrasound detection of increased carotid intima-media thickness and carotid
plaque in an ofﬁce practice setting: does it affect physician behavior or patient motivation? J Am Soc Echocardiogr 2008;21:1156–1162.

Downloaded from https://academic.oup.com/eurjcn/advance-article/doi/10.1093/eurjcn/zvac047/6609451 by Serial Acquisitions Edith Cowan University, Library - Level 2 user on 07 September 2022

such as The Penn State Worry Questionnaire81 to measure worry
may be considered for future interventions.
Also, including psychosocial interventions such as CBSM may
be useful for optimizing the effectiveness of providing vascular
imaging results to participants and reducing the potential harms
of screening. Such support can be important to ensure that individuals who may receive abnormal results do not experience any
form of psychological distress and are not discouraged from participating in future studies or screening programmes. It is recommended that some of these stress management techniques are
included in future cardiovascular screening and other screening
programmes aimed at reducing the burden of non-communicable
diseases. Additionally, psychological assessments must be included in vascular screening interventions and other populationbased CVD screening (ideally, at multiple time points) to identify
individuals who are at an increased risk of experiencing psychological distress immediately or overtime following screening.
Researchers and practitioners can make progress in determining
how to best support individuals at different time points after
screening with adequate information on how individuals react
to screening ﬁndings.

R. Anokye et al.

Psychological distress and quality of life following provision of vascular imaging results

47. Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for
conducting systematic scoping reviews. Int J Evid Based Healthc 2015;13:141–146.
48. Peters MDJ. In no uncertain terms: the importance of a deﬁned objective in scoping
reviews. JBI Evid Synth 2016;14:1–4.
49. Peters MD, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, McInerney P,
Godfrey CM, Khalil H. Updated methodological guidance for the conduct of scoping
reviews. JBI Evid Implement 2021;19:3–10.
50. Mays N, Roberts E, Popay J. Synthesising research evidence. In: Studying the organisation and delivery of health services: Research methods; 2001. p220.
51. Anokye R, Jackson B, Dimmock J, Dickson J, Blekkenhorst L, Hodgson J, Lewis JR,
Stanley M. Psychological distress and quality of life following provision of vascular imaging results of the coronary and carotid arteries to asymptomatic adults: a scoping
review protocol. F1000Res 2021; 9:1376.
52. Obuchowski NA, Holden D, Modic MT, Cheah G, Fu AZ, Brant-Zawadzki M,
Seballos R, Mohammed T-L. Total-body screening: preliminary results of a pilot randomized controlled trial. J Am Coll Radiol 2007;4:604–611.
53. Sandwell JC, Wingard DL, Laughlin GA, Barrett-Connor E. Electron beam computed
tomography screening and heart disease risk factor modiﬁcation. Prev Cardiol 2006;9:
133–137.
54. Schurink M, Braber T, Prakken N, Doevendans P, Backx F, Grobbee D, Rienks R,
Nathoe HM, Bots ML, Velthuis BK, Mosterd A. No psychological distress in sportsmen aged 45 years and older after cardiovascular screening, including cardiac CT: the
Measuring Athlete’s Risk of Cardiovascular events (MARC) study. Neth Heart J 2017;
25:271–277.
55. O’Malley PG, Feuerstein IM, Taylor AJ. Impact of electron beam tomography, with or
without case management, on motivation, behavioral change, and cardiovascular risk
proﬁle: a randomized controlled trial. JAMA 2003;289:2215–2223.
56. Lederman J, Ballard J, Njike VY, Margolies L, Katz DL. Information given to postmenopausal women on coronary computed tomography may inﬂuence cardiac risk reduction efforts. J Clin Epidemiol 2007;60:389–396.
57. Nielsen AD, Videbech P, Gerke O, Petersen H, Jensen JM, Sand NPR, Egstrup K,
Larsen ML, Mickley H, Diederichsen ACP. Population screening for coronary artery
calciﬁcation does not increase mental distress and the use of psychoactive medication. J Thorac Imaging 2012;27:202–206.
58. Rodondi N, Auer R, Devine PJ, O’Malley PG, Hayoz D, Cornuz J. The impact of carotid plaque screening on motivation for smoking cessation. Nicotine Tob Res 2008;
10:541–546.
59. Rodondi N, Collet T-H, Nanchen D, Locatelli I, Depairon M, Aujesky D, Bovet P,
Cornuz J. Impact of carotid plaque screening on smoking cessation and other cardiovascular risk factors: a randomized controlled trial. Arch Intern Med 2012;172:
344–352.
60. Wong ND, Detrano RC, Diamond G, Rezayat C, Mahmoudi R, Chong EC, Tang W,
Puentes G, Kang X, Abrahamson D. Does coronary artery screening by electron
beam computed tomography motivate potentially beneﬁcial lifestyle behaviors?
Am J Cardiol 1996;78:1220–1223.
61. Park P, Simmons RK, Prevost AT, Grifﬁn SJ. Screening for type 2 diabetes is feasible,
acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice. BMC Public Health 2008;8:1–9.
62. Tominaga T, Matsushima M, Nagata T, Moriya A, Watanabe T, Nakano Y, Hirayama
Y, Fujinuma Y. Psychological impact of lifestyle-related disease disclosure at general
checkup: a prospective cohort study. BMC Family Practice 2015;16:1–10.
63. Cockburn J, Staples M, Hurley SF, De Luise T. Psychological consequences of screening mammography. J Med Screen 1994;1:7–12.
64. Walker L, Cordiner C, Gilbert FJ, Needham G, Deans H, Afﬂeck I, Hood DB,
Mathieson D, Ah-See AK, Eremin O. How distressing is attendance for routine
breast screening? Psychooncology 1994;3:299–304.
65. Grupe DW, Nitschke JB. Uncertainty and anticipation in anxiety: an integrated
neurobiological and psychological perspective. Nat Rev Neurosci 2013;14:488–501.
66. Ware JE, Jr., Gandek B. Overview of the SF-36 Health Survey and the International
Quality of Life Assessment (IQOLA) project. J Clin Epidemiol 1998;51:903–912.
67. Fisher GG, Matthews RA, Gibbons AM. Developing and investigating the use of
single-item measures in organizational research. J Occup Health Psychol 2016;21:
3–23.
68. Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of
life: scoping review. SAGE Open Med 2016;4:205031211667172.
69. Saris-Baglama RN, Dewey CJ, Chisholm GB, Plumb E, King J, Kosinski M, et al.
QualityMetric Health Outcomes™ Scoring Software 4.0: Installation Guide. Lincoln, RI:
QualityMetric Incorporated; 2010.
70. Ware J, Kosinski M, Bjorner J, Turner-Bowker D, Gandek B, Maruish M. User’s
Manual for the SF-36v2 Health Survey. 2nd edn. Lincoln, RI: QualityMetric
Incorporated; 2007.
71. Gysels M, Higginson IJ, Rajasekaran M, Davies E, Harding R. Improving Supportive and
Palliative Care for Adults with Cancer: Research Evidence. London: National Institute for
Health and Clinical Excellence; 2004.
72. Holland JC, Andersen B, Breitbart WS, Buchmann LO, Compas B, Deshields TL,
Dudley MM, Fleishman S, Fulcher CD, Greenberg DB, Greiner CB, Handzo GF,

Downloaded from https://academic.oup.com/eurjcn/advance-article/doi/10.1093/eurjcn/zvac047/6609451 by Serial Acquisitions Edith Cowan University, Library - Level 2 user on 07 September 2022

16. Kalia NK, Cespedes L, Youssef G, Li D, Budoff MJ. Motivational effects of coronary
artery calcium scores on statin adherence and weight loss. Coron Artery Dis 2015;26:
225–230.
17. Witte K. Putting the fear back into fear appeals: the extended parallel process model.
Commun Monogr 1992;59:329–349.
18. Lazarus RS, Folkman S. Stress, appraisal, and coping: Springer publishing company;
1984.
19. Gomes AR, Faria S, Lopes H. Stress and psychological health: Testing the mediating
role of cognitive appraisal. West J Nurs Res 2016;38:1448–1468.
20. Craighead WE, Miklowitz DJ, Craighead LW. Psychopathology: History, Diagnosis, and
Empirical Foundations: John Wiley & Sons; 2013.
21. Schneiderman N, Ironson G, Siegel SD. Stress and health: psychological, behavioral,
and biological determinants. Annu Rev Clin Psychol 2005;1:607–628.
22. Oliveira L, Mocaiber I, David IA, Erthal F, Volchan E, Pereira M. Emotion and attention interaction: a trade-off between stimuli relevance, motivation and individual differences. Front Hum Neurosci 2013;7:364.
23. Kalia NK, Miller LG, Nasir K, Blumenthal RS, Agrawal N, Budoff MJ. Visualizing coronary calcium is associated with improvements in adherence to statin therapy.
Atherosclerosis 2006;185:394–399.
24. Orakzai RH, Nasir K, Orakzai SH, Kalia N, Gopal A, Musunuru K, Blumenthal RS,
Budoff MJ. Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneﬁcial lifestyle behaviors. Am J Cardiol 2008;101:
999–1002.
25. Blanchard DC, Defensor EB, Blanchard RJ. Fear, Anxiety, and Defensive Behaviors in
Animals. In: Koob GF Moal ML and Thompson RF (eds.), Encyclopedia of Behavioral
Neuroscience. Oxford: Academic Press; 2010. p532–537.
26. Bodiroga-Vukobrat N, Rukavina D, Pavelić K, Sander GG. Personalized Medicine: A
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